Evidence map›Paper›PMID 37584883›Full record

ArticleBreast cancer research and treatment2023

The impact of nurse navigation on timeliness to treatment for benign high-risk breast pathology.

Catherine S Barker, Catherine W Chung, Rupak Mukherjee, Julie B Siegel, David J Cole, Mark A Lockett, Nancy Klauber-DeMore, Andrea M Abbott

Abstract read
PubMed Publisher
In one paragraph

Article in Breast cancer research and treatment, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Catherine S BarkerDepartment of Surgery, Medical University of South Carolina, Charleston, SC, USA.
Catherine W ChungDepartment of Surgery, Medical University of South Carolina, Charleston, SC, USA.
Rupak MukherjeeDepartment of Surgery, Medical University of South Carolina, Charleston, SC, USA.
Julie B SiegelDepartment of Surgery, Medical University of South Carolina, Charleston, SC, USA. siegelju@musc.edu.
David J ColeDepartment of Surgery, Medical University of South Carolina, Charleston, SC, USA.
Mark A LockettDepartment of Surgery, Medical University of South Carolina, Charleston, SC, USA.
Nancy Klauber-DeMoreDepartment of Surgery, Medical University of South Carolina, Charleston, SC, USA.
Andrea M AbbottDepartment of Surgery, Medical University of South Carolina, Charleston, SC, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeHigh-risk breast pathology is a breast cancer risk factor for which timely treatment is crucial. Nurse navigation programs have been implemented to minimize delays in patient care. This study evaluated nurse navigation in terms of timeliness to surgery for patients with high-risk breast pathology.

methodsThis was a single-institution, retrospective review of patients with identified high-risk breast pathology undergoing lumpectomy between January 2017 and June 2019. Patients were stratified into cohorts based on periods with and without nurse navigation. Preoperative and postoperative time to care as well as demographic and tumor characteristics were compared using univariate and multivariate analysis.

results100 patients had assigned nurse navigators and 29 patients did not. Nurse navigation was associated with reduced time from referral to date of surgery (DOS) by 16.9 days (p = 0.003). Patients > 75 years had a shorter time to first appointment (p = 0.03), and patients with Medicare insurance had a reduced time from referral to DOS (p = 0.005). 20% of all patients were upstaged to cancer on final surgical pathology.

conclusionNurse navigation was significantly associated with decreased time to care for patients with high-risk breast pathology undergoing lumpectomy. We recommend nurse navigation programs as part of a comprehensive approach for patients with high-risk breast pathology.

Indexed as

Breast NeoplasmsPatient NavigationAgedFemaleHumansMedicareReferral and ConsultationRetrospective StudiesUnited StatesBenign breast pathologyHigh-risk breast lesionNurse navigationNurse navigatorPatient navigation

Identifiers

PMID37584883

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.